Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Safety Evaluation of PQ Birch Allergy Immunotherapy to Support Product Development.

Baldrick P, Hutchings JW, Heath MD, Skinner MA.

Regul Toxicol Pharmacol. 2019 Aug 16:104441. doi: 10.1016/j.yrtph.2019.104441. [Epub ahead of print]

PMID:
31425728
2.

Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection.

Cabral-Miranda G, Lim SM, Mohsen MO, Pobelov IV, Roesti ES, Heath MD, Skinner MA, Kramer MF, Martina BEE, Bachmann MF.

Vaccines (Basel). 2019 Jul 23;7(3). pii: E72. doi: 10.3390/vaccines7030072.

3.

New toxicity testing of PQ grass allergy immunotherapy to support product development.

Baldrick P, Hutchings JW, Heath MD, Skinner MA, Martin T, Gray C.

J Appl Toxicol. 2019 Jun 23. doi: 10.1002/jat.3832. [Epub ahead of print]

PMID:
31231859
4.

Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.

Mohsen MO, Heath MD, Cabral-Miranda G, Lipp C, Zeltins A, Sande M, Stein JV, Riether C, Roesti E, Zha L, Engeroff P, El-Turabi A, Kundig TM, Vogel M, Skinner MA, Speiser DE, Knuth A, Kramer MF, Bachmann MF.

J Immunother Cancer. 2019 May 23;7(1):137. doi: 10.1186/s40425-019-0616-y.

5.

Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.

Mohsen MO, Heath MD, Cabral-Miranda G, Lipp C, Zeltins A, Sande M, Stein JV, Riether C, Roesti E, Zha L, Engeroff P, El-Turabi A, Kundig TM, Vogel M, Skinner MA, Speiser DE, Knuth A, Kramer MF, Bachmann MF.

J Immunother Cancer. 2019 Apr 26;7(1):114. doi: 10.1186/s40425-019-0587-z. Erratum in: J Immunother Cancer. 2019 May 23;7(1):137.

6.

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines.

Cabral-Miranda G, M Salman A, O Mohsen M, L Storni F, S Roesti E, A Skinner M, D Heath M, F Kramer M, M Khan S, J Janse C, V S Hill A, F Bachmann M.

Diseases. 2018 Nov 21;6(4). pii: E107. doi: 10.3390/diseases6040107.

7.

Microcrystalline Tyrosine and Aluminum as Adjuvants in Allergen-Specific Immunotherapy Protect from IgE-Mediated Reactivity in Mouse Models and Act Independently of Inflammasome and TLR Signaling.

Leuthard DS, Duda A, Freiberger SN, Weiss S, Dommann I, Fenini G, Contassot E, Kramer MF, Skinner MA, Kündig TM, Heath MD, Johansen P.

J Immunol. 2018 May 1;200(9):3151-3159. doi: 10.4049/jimmunol.1800035. Epub 2018 Mar 28.

8.

Microcrystalline Tyrosine (MCT®): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria.

Cabral-Miranda G, Heath MD, Gomes AC, Mohsen MO, Montoya-Diaz E, Salman AM, Atcheson E, Skinner MA, Kramer MF, Reyes-Sandoval A, Bachmann MF.

Vaccines (Basel). 2017 Sep 27;5(4). pii: E32. doi: 10.3390/vaccines5040032.

9.

Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.

Cabral-Miranda G, Heath MD, Mohsen MO, Gomes AC, Engeroff P, Flaxman A, Leoratti FMS, El-Turabi A, Reyes-Sandoval A, Skinner MA, Kramer MF, Bachmann MF.

Vaccines (Basel). 2017 May 2;5(2). pii: E10. doi: 10.3390/vaccines5020010.

10.

Clinical use of adjuvants in allergen-immunotherapy.

Klimek L, Schmidt-Weber CB, Kramer MF, Skinner MA, Heath MD.

Expert Rev Clin Immunol. 2017 Jun;13(6):599-610. doi: 10.1080/1744666X.2017.1292133. Epub 2017 Feb 23. Review.

PMID:
28162007
11.

A novel microcrystalline tyrosine-adsorbed, mite-allergoid subcutaneous immunotherapy: 1-year follow-up report.

Roger A, Depreux N, Jurgens Y, Serra AT, Heath MD, Garcia G, Skinner MA.

Immunotherapy. 2016 Oct;8(10):1169-74. doi: 10.2217/imt-2016-0068. Epub 2016 Jul 7.

12.

Analysis of aluminium in rat following administration of allergen immunotherapy using either aluminium or microcrystalline-tyrosine-based adjuvants.

McDougall SA, Heath MD, Kramer MF, Skinner MA.

Bioanalysis. 2016 Mar;8(6):547-56. doi: 10.4155/bio.16.10. Epub 2016 Feb 26.

13.

Molecular, proteomic and immunological parameters of allergens provide inclusion criteria for new candidates within established grass and tree homologous groups.

Heath MD, Collis J, Batten T, Hutchings JW, Swan N, Skinner MA.

World Allergy Organ J. 2015 Jul 16;8(1):21. doi: 10.1186/s40413-015-0069-9. eCollection 2015.

14.

A novel and well tolerated mite allergoid subcutaneous immunotherapy: evidence of clinical and immunologic efficacy.

Roger A, Depreux N, Jurgens Y, Heath MD, Garcia G, Skinner MA.

Immun Inflamm Dis. 2014 Aug;2(2):92-8. doi: 10.1002/iid3.23. Epub 2014 May 29.

15.

Interaction of calmodulin with the phosphofructokinase target sequence.

Martin SR, Biekofsky RR, Skinner MA, Guerrini R, Salvadori S, Feeney J, Bayley PM.

FEBS Lett. 2004 Nov 5;577(1-2):284-8.

Supplemental Content

Loading ...
Support Center